Top compounds associated with response to LUZP2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	neratinib	CTRPv2	pan-cancer	AAC	0.081	0.03
mRNA	GSK690693	GDSC1000	pan-cancer	AAC	0.071	0.03
mRNA	JNJ-26854165	GDSC1000	pan-cancer	AAC	0.075	0.03
mRNA	GSK-J4	CTRPv2	pan-cancer	AAC	0.24	0.03
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.081	0.03
mRNA	Sorafenib	FIMM	pan-cancer	AAC	-0.37	0.03
mRNA	KU-0063794	CTRPv2	pan-cancer	AAC	0.079	0.03
mRNA	Rapamycin	CTRPv2	pan-cancer	AAC	0.075	0.03
mRNA	erlotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.083	0.03
mRNA	PHA-665752	GDSC1000	pan-cancer	AAC	0.12	0.04

Download CSV